Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial.

Chacko, Matthews

Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial. [electronic resource] - American heart journal May 2006 - 1032.e1-7 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1097-6744

10.1016/j.ahj.2006.02.012 doi


Aged
Angioplasty, Balloon, Coronary--adverse effects
Anticoagulants--adverse effects
Drug Therapy, Combination
Female
Hemorrhage--chemically induced
Heparin--therapeutic use
Hirudins--adverse effects
Humans
Male
Multicenter Studies as Topic
Myocardial Infarction--etiology
Myocardial Revascularization--statistics & numerical data
Peptide Fragments--adverse effects
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Randomized Controlled Trials as Topic
Recombinant Proteins--adverse effects
Retrospective Studies
Risk Assessment
Sex Factors